The Ensign Group, Inc. (NASDAQ:ENSG – Get Free Report) has been given an average rating of “Moderate Buy” by the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $215.00.
A number of analysts have recently issued reports on ENSG shares. Zacks Research cut The Ensign Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Weiss Ratings lowered The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Royal Bank Of Canada restated an “outperform” rating and issued a $228.00 price target on shares of The Ensign Group in a research note on Tuesday. Wall Street Zen downgraded The Ensign Group from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Truist Financial reduced their price objective on shares of The Ensign Group from $215.00 to $202.00 and set a “hold” rating for the company in a research report on Tuesday, July 14th.
Check Out Our Latest Analysis on ENSG
Insider Activity
Hedge Funds Weigh In On The Ensign Group
Institutional investors and hedge funds have recently made changes to their positions in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in The Ensign Group by 9.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock worth $20,956,000 after purchasing an additional 14,590 shares during the last quarter. Geneos Wealth Management Inc. grew its holdings in The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after buying an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in The Ensign Group by 65.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after buying an additional 213 shares in the last quarter. Amundi grew its holdings in The Ensign Group by 480,216.7% in the 2nd quarter. Amundi now owns 57,638 shares of the company’s stock valued at $8,583,000 after buying an additional 57,626 shares in the last quarter. Finally, Brown Advisory Inc. increased its position in The Ensign Group by 26.1% during the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock worth $314,000 after buying an additional 421 shares during the period. Institutional investors and hedge funds own 96.12% of the company’s stock.
Key The Ensign Group News
Here are the key news stories impacting The Ensign Group this week:
- Positive Sentiment: Q2 earnings beat expectations: Adjusted EPS was $1.92, exceeding the $1.80 consensus estimate and rising 20.8% year over year. GAAP diluted EPS increased 16.7% to $1.68, while revenue climbed 17.3% to $1.44 billion. The Ensign Group Reports Second Quarter 2026 Results
- Positive Sentiment: Guidance was raised: Ensign increased 2026 adjusted EPS guidance to $7.75–$7.85 from $7.48–$7.62 and revenue guidance to $5.87–$5.92 billion from $5.81–$5.86 billion. The new EPS midpoint is projected to grow 18.7% from 2025.
- Positive Sentiment: Operating trends remained favorable: Same-facility occupancy improved to 84.1%, skilled mix revenue increased 10.1%, and management cited clinical quality measures above peer averages and rehospitalization rates below the national average. Ensign also added 20 operations and reported $262.3 million in cash plus $591.6 million of available credit.
- Positive Sentiment: Analyst valuation support: The reported consensus price target is approximately $213.50, implying potential upside relative to recent trading levels. Consensus price target report
- Neutral Sentiment: Insider selling: Director John O. Agwunobi sold 392 shares for approximately $67,056 under a pre-arranged Rule 10b5-1 plan. The transaction reduced his holdings by 3.96%, but the planned nature of the sale limits its significance as a bearish signal.
- Negative Sentiment: Legal overhang persists: Rosen Law Firm and Kaplan Fox announced investigations into potential securities-law violations tied to allegations raised in a Hunterbrook short-seller report concerning staffing, care quality and financial disclosures. The claims remain allegations and could create litigation, regulatory and reputational risks. Kaplan Fox investigation
- Negative Sentiment: Acquisition execution risk: Newly acquired facilities have below-average occupancy and significant clinical and operational challenges, which could pressure margins if integration takes longer than expected.
The Ensign Group Trading Up 2.8%
Shares of NASDAQ:ENSG opened at $183.14 on Wednesday. The Ensign Group has a 52-week low of $141.58 and a 52-week high of $218.00. The company has a market capitalization of $10.70 billion, a P/E ratio of 28.71, a price-to-earnings-growth ratio of 1.74 and a beta of 0.69. The company has a 50-day simple moving average of $165.47 and a 200 day simple moving average of $183.93. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56.
The Ensign Group (NASDAQ:ENSG – Get Free Report) last posted its quarterly earnings results on Monday, July 27th. The company reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.80 by $0.12. The business had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.44 billion. The Ensign Group had a return on equity of 17.12% and a net margin of 6.90%.The Ensign Group’s quarterly revenue was up 16.7% on a year-over-year basis. During the same quarter last year, the company posted $1.59 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Sell-side analysts forecast that The Ensign Group will post 6.82 earnings per share for the current year.
The Ensign Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.1%. The ex-dividend date is Tuesday, June 30th. The Ensign Group’s dividend payout ratio (DPR) is currently 4.08%.
About The Ensign Group
The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.
Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.
Featured Stories
- Five stocks we like better than The Ensign Group
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.
